Physician profile
Benjamin Yarbrough
NPI 1912394651
$1,843.19
in general payments reported to CMS, 2019-2025
9 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $58.02 · 2021: $624 · 2023: $412 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $398.67 | 2021-2025 | Va-Lcp |
| Zimmer Biomet Holdings, INC. | $366.18 | 2019-2021 | |
| Access Pro Medical, LLC | $275.86 | 2023 | Matriderm |
| Integra Lifesciences Corporation | $232.74 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $172.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axogen | $146.81 | 2019-2020 | |
| Tepha INC | $92.93 | 2019 | |
| Coopersurgical, INC. | $85.86 | 2019 | |
| Allergan, INC. | $71.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Yarbrough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.